معرفی
Anirban Basu is a Professor of Health Economics and the Stergachis Family Endowed Director of The CHOICE Institute at the University of Washington School of Pharmacy. He holds joint appointments with the Departments of Health Services and Economics at UW and serves as a Research Associate at the US National Bureau of Economic Research. As an elected Fellow of the American Statistical Association, his academic leadership extends to editorial roles at major journals including serving as Associate Editor for Observational Studies and as an Editorial Advisory Board Member for Value in Health Journal.
Dr. Basu's research sits at the intersection of microeconomics, statistics, and health policy, with three primary focus areas: understanding the economic value of health care, generating causal evidence, and examining potential discrimination with machine learning and AI algorithms. His work spans diverse topics including health technology assessment, cancer treatment value, sickle cell disease economics, diabetes management, and algorithmic fairness in healthcare. He has led numerous federally funded projects including the Value of Information Methods for NHLBI Trials and the Cure Sickle Cell Model for Economic Analysis of Sickle Cell.
The trends in Dr. Basu's recent publications indicate growing emphasis on health equity considerations in economic evaluations, methodological innovations in causal inference, and critical examination of AI applications in healthcare. His work increasingly addresses how to incorporate equity considerations into traditional cost-effectiveness frameworks while advancing methods for analyzing real-world data.
Among his notable scientific honors are:
- 2018 Mid-Career Excellence Award from the Health Policy Statistics Section of the American Statistical Association
- Multiple Research Excellence Awards for Methodological Excellence (2007, 2016)
- Bernie O'Brien New Investigator Award from ISPOR (2009)
- Alan Williams Health Economics Fellowship from University of York (2008)
- Labelle Lectureship in Health Economics from McMaster University (2009)
Dr. Basu has served on the 2nd Panel on Cost-effectiveness Analysis in Health and Medicine and as Associate Editor for Health Economics and the Journal of Health Economics. He has been involved in numerous research grants from agencies including NIH, AHRQ, NHLBI, and ICER, with recent projects focusing on value-based pricing, comparative effectiveness of treatments, and health disparities. His leadership extends to directing The CHOICE Institute's Annual Health Econometrics Workshop and contributing to the Pacific Northwest Evidence-based Practice Center's systematic reviews.
At the University of Washington, Dr. Basu directs The CHOICE Institute, a research and education center focused on comparative health outcomes, policy, and economics. The Institute collaborates with major initiatives like the Institute for Clinical and Economic Review (ICER) and works with decision makers including patients, physicians, industry, and payers at regional, national, and global levels. Current research directions include addressing national healthcare challenges related to the Affordable Care Act, personalized medicines, medication adherence, healthcare technology, and international collaborations through the Global Medicines Program.
